Oroxylin A Inhibits Colitis-associated Carcinogenesis Through Modulating the IL-6/STAT3 Signaling Pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oroxylin A Inhibits Colitis-associated Carcinogenesis Through Modulating the IL-6/STAT3 Signaling Pathway
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume -, Issue -, Pages 1
Publisher
Oxford University Press (OUP)
Online
2013-07-04
DOI
10.1097/mib.0b013e318293c5e0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-Induced STAT3 phosphorylation in human hepatocellular cancer cells
- (2010) Yan Liu et al. CELL CYCLE
- Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction
- (2010) Ji Hyun Choi et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
- (2010) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer
- (2010) Emily L. Lowe et al. PLoS One
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice
- (2009) Shingo Miyamoto et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inflammation and colorectal cancer
- (2009) Sarah Kraus et al. CURRENT OPINION IN PHARMACOLOGY
- Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
- (2009) Stefan Rose-John et al. CURRENT PHARMACEUTICAL DESIGN
- Frequency of and variables associated with the EGFR mutation and its subtypes
- (2009) Tomoaki Tanaka et al. INTERNATIONAL JOURNAL OF CANCER
- Involvement of p53 in oroxylin A-induced apoptosis in cancer cells
- (2009) Rong Mu et al. MOLECULAR CARCINOGENESIS
- Inhibitory effects on bacterial growth and b-ketoacyl-ACP reductase by different species of maple leaf extracts and tannic acid
- (2009) Dan Wu et al. PHYTOTHERAPY RESEARCH
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
- (2008) Shuiping Tu et al. CANCER CELL
- Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells
- (2008) Yu Sun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- 5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis
- (2008) Margie L. Clapper et al. INFLAMMATORY BOWEL DISEASES
- NF-κB in inflammatory bowel disease
- (2008) I. Atreya et al. JOURNAL OF INTERNAL MEDICINE
- Inflammation: Gearing the journey to cancer
- (2008) J KUNDU et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Molecular basis of the potential of mesalazine to prevent colorectal cancer
- (2008) Carmine Stolfi et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now